Alnylam Pharmaceuticals (ALNY) EBITDA US GAAP (year values)

2019 2020 2021 2022 2023   LTM ? CAGR 5 years ?
EBITDA, bln rub ? -868.1 -736.3 -661.6 -926.6 -258.2   -130.9  
Changes by years, y/y, % +4% -15% -10% +40% -72%     -20.9%

Alnylam Pharmaceuticals. EBITDA US GAAP, bln rub

Created with Highcharts 6.0.6-4.2-4.2-19.6-19.6-29.8-29.8-40.4-40.4-35.7-35.7-76.1-76.1-18.9-18.9-41.0-41.0-38.1-38.1-49.7-49.7-107.6-107.6-81.7-81.7-388.7-388.7-277.0-277.0-409.5-409.5-465.3-465.3-835.2-835.2-868.1-868.1-736.3-736.3-661.6-661.6-926.6-926.6-258.2-258.2-130.9-130.92002200320042005200620072008200920102011201220132014201520162017201820192020202120222023LTM-1000-800-600-400-2000smart-lab.ru

Alnylam Pharmaceuticals. EBITDA US GAAP, changes, %

Created with Highcharts 6.0.6368.5368.552.152.135.335.3-11.6-11.6113.4113.4-75.1-75.1116.6116.6-7.2-7.230.630.6116.4116.4-24.0-24.0375.8375.8-28.7-28.747.847.813.613.679.579.53.93.9-15.2-15.2-10.2-10.240.140.1-72.1-72.1-49.3-49.3200320042005200620072008200920102011201220132014201520162017201820192020202120222023LTM-1000100200300400smart-lab.ru

Alnylam Pharmaceuticals. EBITDA US GAAP, sum by quarters, bln rub

Created with Highcharts 6.0.6-20.6-20.6-4.8-4.8-14.2-14.2-8.9-8.92.62.6-7.5-7.5-7.1-7.1-5.2-5.2-12.3-12.3-70.7-70.7-26.7-26.7-40.1-40.1-87.4-87.4-112.4-112.4-143.6-143.6-213.3-213.3-261.8-261.8-204.7-204.7-202.0-202.0-177.1-177.1-92.9-92.9-12.8-12.8-5.7-5.7-9.9-9.9-7.6-7.6-46.6-46.6-2.0-2.0-8.6-8.6-8.1-8.1-11.2-11.2-15.9-15.9-29.2-29.2-40.8-40.8-73.1-73.1-103.2-103.2-122.2-122.2-241.6-241.6-191.3-191.3-215.1-215.1-140.7-140.7-234.7-234.7195.0195.0-60.3-60.3-10.3-10.3-10.2-10.2-14.0-14.0-10.2-10.2-19.9-19.9-13.6-13.6-11.8-11.8-9.5-9.5-18.3-18.3-41.5-41.5-66.3-66.3-88.4-88.4-117.4-117.4-161.2-161.2-208.8-208.8-142.5-142.5-132.8-132.8-168.5-168.5-244.2-244.237.137.1-6.5-6.5-6.0-6.0-9.0-9.0-22.8-22.8-0.1-0.1-5.4-5.4-11.1-11.1-14.3-14.3-8.8-8.8-7.4-7.4-266.2-266.2-47.5-47.5-105.4-105.4-103.5-103.5-138.1-138.1-169.0-169.0-164.6-164.6-154.2-154.2-142.6-142.6-143.4-143.4-14.8-14.84 quarter3 quarter2 quarter1 quarter200320042005200620072008200920102011201220132014201520162017201820192020202120222023202422-1000-750-500-2500250500smart-lab.ru

Alnylam Pharmaceuticals (ALNY) EBITDA US GAAP (quarter values)

2023Q3 2023Q4 2024Q1 2024Q2 2024Q3   LTM ?
EBITDA, bln rub ? 195.0 -92.9 -14.8 37.1 -60.3   -130.9
Changes by years, y/y, % -183% -48% -90% -115% -131%    
Changes by quarters, q/q, % -180% -148% -84% -350% -263%    

Alnylam Pharmaceuticals. EBITDA US GAAP, bln rub

Created with Highcharts 6.0.6-20.6-20.6-12.8-12.8-6.5-6.5-5.7-5.7-4.8-4.8-6.0-6.0-10.3-10.3-9.9-9.9-14.2-14.2-9.0-9.0-10.2-10.2-7.6-7.6-8.9-8.9-22.8-22.8-14.0-14.0-46.6-46.62.62.6-0.1-0.1-10.2-10.2-2.0-2.0-7.5-7.5-5.4-5.4-19.9-19.9-8.6-8.6-7.1-7.1-11.1-11.1-13.6-13.6-8.1-8.1-5.2-5.2-14.3-14.3-11.8-11.8-11.2-11.2-12.3-12.3-8.8-8.8-9.5-9.5-15.9-15.9-70.7-70.7-7.4-7.4-18.3-18.3-29.2-29.2-26.7-26.7-266.2-266.2-41.5-41.5-40.8-40.8-40.1-40.1-47.5-47.5-66.3-66.3-73.1-73.1-87.4-87.4-105.4-105.4-88.4-88.4-103.2-103.2-112.4-112.4-103.5-103.5-117.4-117.4-122.2-122.2-143.6-143.6-138.1-138.1-161.2-161.2-241.6-241.6-213.3-213.3-169.0-169.0-208.8-208.8-191.3-191.3-261.8-261.8-164.6-164.6-142.5-142.5-215.1-215.1-204.7-204.7-154.2-154.2-132.8-132.8-140.7-140.7-202.0-202.0-142.6-142.6-168.5-168.5-234.7-234.7-177.1-177.1-143.4-143.4-244.2-244.2195.0195.0-92.9-92.9-14.8-14.837.137.1-60.3-60.32003Q42004Q12004Q42005Q22005Q42006Q22006Q42007Q22007Q42008Q22008Q42009Q22009Q42010Q22010Q42011Q22011Q42012Q22012Q42013Q22013Q42014Q22014Q42015Q22015Q42016Q22016Q42017Q22017Q42018Q22018Q42019Q22019Q42020Q22020Q42021Q22021Q42022Q22022Q42023Q22023Q42024Q2-300-200-1000100200300smart-lab.ru

Alnylam Pharmaceuticals. EBITDA US GAAP, changes, y/y, %

Created with Highcharts 6.0.6-76.8-76.8-7.9-7.974.374.3196.3196.350.050.0-0.9-0.9-23.3-23.3-37.1-37.1153.1153.137.937.9511.7511.7-129.5-129.5-99.6-99.6-27.5-27.5-95.7-95.7-387.3-387.36432.56432.595.395.3328.2328.2-5.9-5.9105.5105.5-31.3-31.3-6.7-6.7-26.5-26.528.728.7-13.2-13.238.638.6136.9136.9-38.8-38.8-20.0-20.041.941.9472.8472.8-15.1-15.193.893.884.084.0-62.2-62.23474.33474.3126.4126.439.839.850.350.3-82.2-82.259.859.879.079.0117.9117.9121.9121.933.333.341.241.228.628.6-1.8-1.832.832.818.518.527.727.733.433.437.337.397.797.748.648.622.422.429.529.5-20.8-20.822.722.7-2.6-2.6-31.8-31.812.512.5-21.8-21.8-6.4-6.4-6.8-6.8-34.6-34.6-1.3-1.3-7.5-7.526.926.966.866.8-12.3-12.30.60.644.944.9-183.1-183.1-47.6-47.6-89.7-89.7-115.2-115.2-130.9-130.92004Q42005Q32006Q12006Q32007Q12007Q32008Q12008Q32009Q12009Q32010Q12010Q32011Q12011Q32012Q12012Q32013Q12013Q32014Q12014Q32015Q12015Q32016Q12016Q32017Q12017Q32018Q12018Q32019Q12019Q32020Q12020Q32021Q12021Q32022Q12022Q32023Q12023Q32024Q12024Q3-2k02k4k6k8ksmart-lab.ru

Alnylam Pharmaceuticals. EBITDA US GAAP, changes, q/q, %

Created with Highcharts 6.0.6-37.7-37.7-49.1-49.1-12.6-12.6-16.1-16.125.625.670.770.7-3.1-3.142.642.6-36.4-36.412.812.8-25.1-25.117.017.0156.1156.1-38.5-38.5232.2232.2-105.6-105.6-103.2-103.212144.612144.6-80.1-80.1273.2273.2-28.1-28.1266.1266.1-56.4-56.4-18.0-18.057.157.122.422.4-40.9-40.9-35.4-35.4175.1175.1-17.5-17.5-5.5-5.510.510.5-29.0-29.07.97.967.667.6345.9345.9-89.5-89.5146.3146.359.259.2-8.5-8.5896.7896.7-84.4-84.4-1.7-1.7-1.6-1.618.418.439.639.610.110.119.719.720.620.6-16.1-16.116.716.79.09.0-7.9-7.913.413.44.14.117.517.5-3.8-3.816.816.849.849.8-11.7-11.7-20.8-20.823.523.5-8.4-8.436.936.9-37.1-37.1-13.5-13.551.051.0-4.9-4.9-24.7-24.7-13.9-13.96.06.043.543.5-29.4-29.418.218.239.339.3-24.5-24.5-19.0-19.070.370.3-179.8-179.8-147.6-147.6-84.0-84.0-350.3-350.3-262.6-262.62004Q32004Q32005Q12005Q32006Q12006Q32007Q12007Q32008Q12008Q32009Q12009Q32010Q12010Q32011Q12011Q32012Q12012Q32013Q12013Q32014Q12014Q32015Q12015Q32016Q12016Q32017Q12017Q32018Q12018Q32019Q12019Q32020Q12020Q32021Q12021Q32022Q12022Q32023Q12023Q32024Q12024Q3-2.5k02.5k5k7.5k10k12.5k15ksmart-lab.ru